Han Wei, Shi Jia, Cao Jiachao, Dong Bo, Guan Wei
Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou, People's Republic of China.
Onco Targets Ther. 2020 Jul 16;13:6937-6955. doi: 10.2147/OTT.S260376. eCollection 2020.
Glioma is the most common type of intracranial malignant tumor, with a great recurrence rate due to its infiltrative growth, treatment resistance, intra- and intertumoral genetic heterogeneity. Recently, accumulating studies have illustrated that activated aerobic glycolysis participated in various cellular and clinical activities of glioma, thus influencing the efficacy of radiotherapy and chemotherapy. However, the glycolytic process is too complicated and ambiguous to serve as a novel therapy for glioma. In this review, we generalized the implication of key enzymes, glucose transporters (GLUTs), signalings and transcription factors in the glycolytic process of glioma. In addition, we summarized therapeutic interventions via the above aspects and discussed promising clinical applications for glioma.
胶质瘤是最常见的颅内恶性肿瘤类型,由于其浸润性生长、治疗抵抗、肿瘤内和肿瘤间的基因异质性,复发率很高。最近,越来越多的研究表明,激活的有氧糖酵解参与了胶质瘤的各种细胞和临床活动,从而影响放疗和化疗的疗效。然而,糖酵解过程过于复杂和模糊,无法作为胶质瘤的一种新疗法。在这篇综述中,我们总结了关键酶、葡萄糖转运蛋白(GLUTs)、信号通路和转录因子在胶质瘤糖酵解过程中的作用。此外,我们总结了通过上述方面的治疗干预措施,并讨论了胶质瘤有前景的临床应用。